Shares of Edap Tms SA (NASDAQ:EDAP) have been given a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.
Brokerages have set a one year consensus price objective of $6.50 for the company and are anticipating that the company will post ($0.02) EPS for the current quarter, according to Zacks. Zacks has also given Edap Tms an industry rank of 121 out of 255 based on the ratings given to its competitors.
A number of analysts recently issued reports on EDAP shares. HC Wainwright reissued a “buy” rating and set a $6.50 price target on shares of Edap Tms in a report on Wednesday, May 16th. ValuEngine cut shares of Edap Tms from a “buy” rating to a “hold” rating in a report on Saturday, June 16th. Finally, TheStreet raised shares of Edap Tms from a “d+” rating to a “c” rating in a report on Tuesday, June 26th.
An institutional investor recently raised its position in Edap Tms stock. Archon Capital Management LLC boosted its holdings in shares of Edap Tms SA (NASDAQ:EDAP) by 7.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,019,011 shares of the medical equipment provider’s stock after acquiring an additional 71,336 shares during the quarter. Edap Tms accounts for about 0.2% of Archon Capital Management LLC’s investment portfolio, making the stock its 14th largest holding. Archon Capital Management LLC owned 3.51% of Edap Tms worth $2,364,000 as of its most recent SEC filing. 9.67% of the stock is owned by hedge funds and other institutional investors.
Shares of NASDAQ:EDAP remained flat at $$3.14 during trading on Friday. The stock had a trading volume of 19,752 shares, compared to its average volume of 63,877. Edap Tms has a one year low of $2.07 and a one year high of $4.25. The firm has a market cap of $91.05 million, a price-to-earnings ratio of -314.00 and a beta of 0.62. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.45 and a quick ratio of 2.04.
Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Monday, May 14th. The medical equipment provider reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.05. Edap Tms had a negative return on equity of 5.89% and a negative net margin of 5.98%. The firm had revenue of $11.28 million during the quarter, compared to analysts’ expectations of $10.46 million. equities research analysts anticipate that Edap Tms will post -0.01 EPS for the current fiscal year.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
See Also: Dividend
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.